ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 121 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $362,422,448 | +3.1% | 17,687,772 | 0.0% | 7.65% | +14.3% |
Q2 2023 | $351,456,030 | +16.0% | 17,687,772 | 0.0% | 6.69% | +6.1% |
Q1 2023 | $302,991,534 | -12.5% | 17,687,772 | 0.0% | 6.31% | -10.7% |
Q4 2022 | $346,149,698 | +37.2% | 17,687,772 | +11.9% | 7.07% | +21.5% |
Q3 2022 | $252,213,000 | +16.0% | 15,802,802 | 0.0% | 5.82% | +3.5% |
Q2 2022 | $217,447,000 | -13.2% | 15,802,802 | 0.0% | 5.62% | +8.3% |
Q1 2022 | $250,632,000 | -27.3% | 15,802,802 | 0.0% | 5.19% | +3.0% |
Q4 2021 | $344,975,000 | -26.5% | 15,802,802 | 0.0% | 5.04% | -28.9% |
Q3 2021 | $469,601,000 | -29.3% | 15,802,802 | +5.4% | 7.08% | -29.3% |
Q2 2021 | $663,920,000 | -4.8% | 14,990,286 | -4.6% | 10.02% | -8.0% |
Q1 2021 | $697,287,000 | -25.5% | 15,715,286 | -7.9% | 10.88% | -30.7% |
Q4 2020 | $935,582,000 | +143.4% | 17,060,211 | +1.5% | 15.70% | +69.6% |
Q3 2020 | $384,334,000 | +9.2% | 16,812,491 | 0.0% | 9.25% | -6.5% |
Q2 2020 | $351,885,000 | +50.0% | 16,812,491 | 0.0% | 9.90% | -1.9% |
Q1 2020 | $234,534,000 | -38.7% | 16,812,491 | 0.0% | 10.10% | -30.1% |
Q4 2019 | $382,652,000 | +98.8% | 16,812,491 | +1.4% | 14.44% | +26.1% |
Q3 2019 | $192,503,000 | -22.6% | 16,587,491 | 0.0% | 11.45% | -13.9% |
Q2 2019 | $248,812,000 | -11.2% | 16,587,491 | +3.4% | 13.29% | -30.5% |
Q1 2019 | $280,250,000 | +18.8% | 16,037,486 | 0.0% | 19.13% | -12.9% |
Q4 2018 | $235,848,000 | -36.0% | 16,037,486 | +7.1% | 21.95% | -0.5% |
Q3 2018 | $368,555,000 | +27.3% | 14,969,744 | 0.0% | 22.07% | +5.7% |
Q2 2018 | $289,448,000 | +12.1% | 14,969,744 | 0.0% | 20.88% | -15.1% |
Q1 2018 | $258,228,000 | – | 14,969,744 | – | 24.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |